the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Lunenfeld-Tanenbaum Research Institute University of Toronto

Targeting the rodent and human L cell using insulin-propionate GLP-1 synthesis and secretion, and degradation or the NOTCH inhibitor dibenzazepine Gut endocrine cells

Manipulating glucagon action in the ischemic mouse heart-what are the implications? Glucagon Receptor Antagonists

Can a synthetic triagonist containing glucagon, GLP-1 and GIP mimic the metabolic actions of bariatric surgery? See Gut hormones and bariatric surgery


Save the date-Incretin 2015-The 45th Anniversary of GIP and more: Vancouver July 29-August 1 2015


For updates to, Follow us on Twitter DanielJDrucker